EcoDrugPlus

Ensembl ID : ML282541a
Gene Symbol: -
External references: -
103 Possible Orthologues:

Ensembl ID : ML28258a
Gene Symbol: -
External references: -
78 Possible Orthologues:

Ensembl ID : ML289710a
Gene Symbol: -
External references: -
268 Possible Orthologues:

Ensembl ID : ML29499a
Gene Symbol: -
External references: -
178 Possible Orthologues:

Ensembl ID : ML29541a
Gene Symbol: -
External references: -
261 Possible Orthologues:

Ensembl ID : ML29542a
Gene Symbol: -
External references: -
275 Possible Orthologues:

Ensembl ID : ML296213a
Gene Symbol: -
External references: -
197 Possible Orthologues:

Ensembl ID : ML296220a
Gene Symbol: -
External references: -
315 Possible Orthologues:

Ensembl ID : ML29622a
Gene Symbol: -
External references: -
112 Possible Orthologues:

Ensembl ID : ML305510a
Gene Symbol: -
External references: -
186 Possible Orthologues:

Ensembl ID : ML305514a
Gene Symbol: -
External references: -
62 Possible Orthologues:

Ensembl ID : ML305520a
Gene Symbol: -
External references: -
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).